A detailed history of Lifeworks Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Lifeworks Advisors, LLC holds 22,705 shares of AMGN stock, worth $6.66 Million. This represents 1.1% of its overall portfolio holdings.

Number of Shares
22,705
Previous 18,731 21.22%
Holding current value
$6.66 Million
Previous $6.04 Million 1.96%
% of portfolio
1.1%
Previous 1.22%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025

BUY
$258.78 - $328.31 $1.03 Million - $1.3 Million
3,974 Added 21.22%
22,705 $5.92 Million
Q3 2024

Nov 06, 2024

SELL
$309.38 - $337.38 $51,975 - $56,679
-168 Reduced 0.89%
18,731 $6.04 Million
Q2 2024

Aug 13, 2024

BUY
$262.75 - $319.31 $459,024 - $557,834
1,747 Added 10.19%
18,899 $5.9 Million
Q1 2024

May 10, 2024

BUY
$268.87 - $324.56 $573,768 - $692,611
2,134 Added 14.21%
17,152 $4.88 Million
Q4 2023

Feb 12, 2024

SELL
$255.7 - $288.46 $139,100 - $156,922
-544 Reduced 3.5%
15,018 $4.33 Million
Q3 2023

Nov 01, 2023

BUY
$218.65 - $271.46 $279,653 - $347,197
1,279 Added 8.95%
15,562 $4.18 Million
Q2 2023

Aug 02, 2023

BUY
$214.27 - $253.37 $582,814 - $689,166
2,720 Added 23.52%
14,283 $3.17 Million
Q1 2023

May 15, 2023

SELL
$225.79 - $275.2 $122,378 - $149,158
-542 Reduced 4.48%
11,563 $2.8 Million
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $88,634 - $112,620
387 Added 3.3%
12,105 $3.18 Million
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $47,585 - $53,667
212 Added 1.84%
11,718 $3.17 Million
Q2 2022

Aug 12, 2022

BUY
$230.71 - $256.74 $195,180 - $217,202
846 Added 7.94%
11,506 $2.8 Million
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $1.12 Million - $1.24 Million
5,126 Added 92.63%
10,660 $2.58 Million
Q4 2021

Feb 15, 2022

BUY
$198.88 - $227.6 $1.1 Million - $1.26 Million
5,534 New
5,534 $1.25 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $157B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Lifeworks Advisors, LLC Portfolio

Follow Lifeworks Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lifeworks Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lifeworks Advisors, LLC with notifications on news.